HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frequent expression of thymidine phosphorylase in Epstein-Barr virus-associated gastric carcinoma of diffuse type.

AbstractUNLABELLED:
The aim of the present study was to elucidate the etiological roles of Epstein-Barr virus (EBV) in the development of EBV-associated GC (EBV-GC), EBV-GCs and non EBV-GCs were compared with regard to the expression of thymidine phosphorylase (TP), which is known to have angiogenic activity in various tumor tissues.
PATIENTS AND METHODS:
TP expression was examined by immunohistochemistry assay among 156 gastric carcinoma cases (21 EBV-GC cases and 135 non EBV-GC cases).
RESULTS:
The frequency of tumors with TP expression was nearly twice as high in EBV-GCs (71%) than in non EBV-GCs (37%) (p=0.005). However, such an association was only observed in Lauren's diffuse-type tumors.
CONCLUSION:
Our finding suggests that the mechanism involved in TP expression of gastric carcinoma appears to be different in intestinal- and diffuse-type tumors.
AuthorsChihaya Koriyama, Suminori Akiba, Shunji Shimaoka, Tetsuhiko Itoh, Shin-ichi Akiyama, Yoshito Eizuru
JournalAnticancer research (Anticancer Res) Vol. 30 Issue 6 Pg. 2431-7 (Jun 2010) ISSN: 1791-7530 [Electronic] Greece
PMID20651404 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ki-67 Antigen
  • RNA, Viral
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • Thymidine Phosphorylase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Herpesvirus 4, Human (genetics, isolation & purification)
  • Humans
  • Interferon-gamma (genetics)
  • Ki-67 Antigen (analysis)
  • Male
  • Middle Aged
  • RNA, Viral (analysis)
  • Stomach Neoplasms (enzymology, pathology, virology)
  • Thymidine Phosphorylase (analysis)
  • Tumor Necrosis Factor-alpha (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: